Page last updated: 2024-11-02

pioglitazone and Leanness

pioglitazone has been researched along with Leanness in 4 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"The effects of dietary fructose alone or in combination with a new oral agent, pioglitazone, on VLDL-triglyceride (TG) turnover were studied in genetically obese Wistar fatty rats characterized by hyperinsulinemia (7,488 +/- 954 pmol/l), hyperglycemia, (22."1.29VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone. ( Amano, N; Ebara, T; Hirano, T; Hozumi, T; Ishida, Y; Kazumi, T; Odaka, H; Yoshino, G, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sonta, T1
Inoguchi, T1
Tsubouchi, H1
Sekiguchi, N1
Kobayashi, K1
Matsumoto, S1
Utsumi, H1
Nawata, H1
Bhat, R1
Bhansali, A1
Bhadada, S1
Sialy, R1
Kazumi, T1
Hirano, T1
Odaka, H1
Ebara, T1
Amano, N1
Hozumi, T1
Ishida, Y1
Yoshino, G1
de Souza, CJ1
Eckhardt, M1
Gagen, K1
Dong, M1
Chen, W1
Laurent, D1
Burkey, BF1

Trials

1 trial available for pioglitazone and Leanness

ArticleYear
Effect of pioglitazone therapy in lean type 1 diabetes mellitus.
    Diabetes research and clinical practice, 2007, Volume: 78, Issue:3

    Topics: Blood Glucose; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glycated Hemoglobin; Humans; Hy

2007

Other Studies

3 other studies available for pioglitazone and Leanness

ArticleYear
Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity.
    Free radical biology & medicine, 2004, Jul-01, Volume: 37, Issue:1

    Topics: Animals; Diabetes Mellitus, Experimental; Disease Models, Animal; Electron Spin Resonance Spectrosco

2004
VLDL triglyceride kinetics in Wistar fatty rats, an animal model of NIDDM: effects of dietary fructose alone or in combination with pioglitazone.
    Diabetes, 1996, Volume: 45, Issue:6

    Topics: Animals; Body Weight; Cholesterol; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Disease Models,

1996
Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance.
    Diabetes, 2001, Volume: 50, Issue:8

    Topics: Adipocytes; Adipose Tissue; Analysis of Variance; Animals; Blood Glucose; Cell Division; Cell Size;

2001